Form 4: Aethlon Medical Director Edward Broenniman Reports Tax Withholding Share Disposal

Director Edward Broenniman reports the disposal of 1,163 common stock shares of Aethlon Medical Inc. to cover tax obligations upon vesting of a restricted stock unit (RSU).

Summary

• On March 29, 2024, Edward Broenniman, a director of Aethlon Medical Inc. (AEMD), reported a transaction involving the disposal of 1,163 shares of common stock.
• The shares were disposed of to cover tax withholding obligations related to the vesting of a restricted stock unit (RSU) that was dated April 28, 2023.
• The transaction was executed at a price of $1.68 per share.
• Following the transaction, Broenniman directly owns 12,570 shares of Aethlon Medical Inc.

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations, so it doesn't significantly impact sentiment positively or negatively.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders (directors, officers, and principal stockholders) of publicly traded companies, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.

Key Dates

Keywords

Aethlon Medical, AEMD, Edward Broenniman, Form 4, Director, Share Disposal, Tax Withholding, RSU, Common Stock, Securities